The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wapnick Pamela since 2024.
This trader's CIK number is 1995657.
At the time of last reporting, Wapnick Pamela was the Chief Financial Officer of Metagenomi Therapeutics, Inc.. (stock ticker symbol MGX).
Also see all insider trading activities at Metagenomi Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | MGX | 0 | $0 | 1,581 | $2,529 | 0 | $0 |
| 2025 | MGX | 0 | $0 | 6,536 | $11,792 | 0 | $0 |
| 2024 | MGX | 0 | $0 | 7,824 | $20,942 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-05 | MGX | Sale | 1,581 | 1.60 | 2,529 |
| 2025-12-05 | MGX | Sale | 1,576 | 1.77 | 2,792 |
| 2025-09-05 | MGX | Sale | 1,576 | 1.81 | 2,852 |
| 2025-06-06 | MGX | Sale | 1,576 | 1.75 | 2,758 |
| 2025-03-05 | MGX | Sale | 1,808 | 1.88 | 3,390 |
| 2024-12-05 | MGX | Sale | 1,559 | 1.86 | 2,899 |
| 2024-09-05 | MGX | Sale | 6,265 | 2.88 | 18,043 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wapnick Pamela (Chief Financial Officer of Metagenomi Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.